Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Kleeberger

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cureus|July 7, 2025
Virtual Patients in Clinical Trials for Drug Development: A Narrative ReviewJan A Kleeberger
Advances in Experimental Medicine and Biology|April 15, 2020
Non-coding RNA and Cardiac Electrophysiological DisordersJan A Kleeberger, Philipp J Tomsits, Stefan Kääb, et al.
Transplantation|September 23, 2016
MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft VasculopathyAnneke Neumann, L Christian Napp, Jan A Kleeberger, et al.
Frontiers in Cardiovascular Medicine|June 12, 2026
Partner valves: role of a prospective device selection strategy using ACURATE and SAPIEN 3 as complementary devices in transcatheter aortic valve implantationJonathan M Michel, Mi Chen, Neria E Winkler, et al.
European Heart Journal|July 14, 2020
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophyJanika Viereck, Anne Bührke, Ariana Foinquinos, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cureus|July 7, 2025
Virtual Patients in Clinical Trials for Drug Development: A Narrative ReviewJan A Kleeberger
Advances in Experimental Medicine and Biology|April 15, 2020
Non-coding RNA and Cardiac Electrophysiological DisordersJan A Kleeberger, Philipp J Tomsits, Stefan Kääb, et al.
Transplantation|September 23, 2016
MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft VasculopathyAnneke Neumann, L Christian Napp, Jan A Kleeberger, et al.
Frontiers in Cardiovascular Medicine|June 12, 2026
Partner valves: role of a prospective device selection strategy using ACURATE and SAPIEN 3 as complementary devices in transcatheter aortic valve implantationJonathan M Michel, Mi Chen, Neria E Winkler, et al.
European Heart Journal|July 14, 2020
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophyJanika Viereck, Anne Bührke, Ariana Foinquinos, et al.
Pageof 1